RARITAN, N.J.--(BUSINESS WIRE)--Ortho-Clinical Diagnostics, Inc. (OCD) today announced that it obtained Health Canada approval for the ORTHO VISION™ Analyzer, a highly interactive, fully automated ...
Ortho Clinical Diagnostics today announced that Terre Haute Regional Hospital is the first U.S. medical center to install the ORTHO VISION TM Analyzer, a highly interactive, fully automated analyzer ...
RARITAN, N.J., May 3, 2021 /PRNewswire/ — Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world’s largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ...
RARITAN, NJ--(Marketwired - Apr 28, 2016) - Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, today announced that ORTHO™ Sera, a fully automated solution for extended ...
RARITAN, NJ--(Marketwired - Nov 12, 2015) - Ortho Clinical Diagnostics today announced that Terre Haute Regional Hospital is the first U.S. medical center to install the ORTHO VISION™ Analyzer, a ...
RARITAN, N.J., July 26, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced its semi-automated ORTHO ...
RARITAN, N.J., May 3, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ...
RARITAN, N.J., May 3, 2021 /PRNewswire/ -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced the availability of enhanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback